Skip to main content

LINCOLN NATIONAL CORP

For the period ended Mar 31, 2024. Filed May 2, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2024 · Filed May 2, 2024

LNC$42.98+7.3%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Results of Group Protection

Details underlying the results for Group Protection (in millions) were as follows:

For the Three Months Ended March 31,
20242023
Operating Revenues
Insurance premiums$1,285$1,251
Net investment income8585
Other revenues (1)5552
Total operating revenues1,4251,388
Operating Expenses
Benefits1,0301,037
Interest credited11
Policyholder liability remeasurement
(gain) loss(67)(100)
Commissions and other expenses360361
Total operating expenses1,3241,299
Income (loss) from operations before taxes10189
Federal income tax expense (benefit)2118
Income (loss) from operations$80$71

(1)Consists of revenue from third parties for administrative services performed, which has a corresponding partial offset in commissions and other expenses.

For the Three Months Ended March 31,
20242023
Income (Loss) from Operations by Product Line
Life$9$(3)
Disability7377
Dental(2)(3)
Income (loss) from operations$80$71

Income from operations for this segment increased due primarily to higher insurance premiums due to growth in business in force.

The increase in income from operations was partially offset by higher total benefits and policyholder liability remeasurement (gain) loss driven by higher claim experience in our disability business.

For information about the effect of the loss ratio sensitivity on our income (loss) from operations, see “Part II – Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations – Results of Group Protection – Additional Information” in our 2023 Form 10-K.

For information on the effects of current interest rates on our long-term disability claim reserves, see “Item 3. Quantitative and Qualitative Disclosures About Market Risk – Interest Rate Risk – Effect of Interest Rate Sensitivity” in our 2023 Form 10-K. For information on the interest rate environment, see “Part II – Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations – Introduction – Executive Summary” in our 2023 Form 10-K.

Insurance Premiums

Details underlying insurance premiums (in millions) were as follows:

For the Three Months Ended March 31,
20242023
Insurance Premiums by Product Line
Life$499$480
Disability740725
Dental4646
Total insurance premiums$1,285$1,251
Sales by Product Line
Life$85$82
Disability5140
Dental86
Total sales$144$128

Premiums are a function of the rates priced into the product and our business in force. Business in force, in turn, is driven by sales and persistency experience.

Sales relate to new policyholders and new coverages sold to existing policyholders. We believe that the trend in sales is an important indicator of development of business in force over time. Sales in the table above are the combined annualized premiums for our products.

Net Investment Income

We use our investment income to offset the earnings effect of the associated build of our reserves, which are a function of our insurance premiums and the yields on our investments. Details underlying net investment income (in millions) were as follows:

For the Three Months Ended March 31,
20242023
Net Investment Income
Fixed maturity AFS securities, mortgage loans on real estate
and other, net of investment expenses$68$67
Surplus investments (2)1718
Total net investment income$85$85

(2)Represents net investment income on the required statutory surplus for this segment and includes the effect of investment income on alternative investments for such assets that are held in the portfolios supporting statutory surplus versus the portfolios supporting product liabilities. See “Consolidated Investments – Alternative Investments” below for more information on alternative investments.

Benefits, Interest Credited and Policyholder Liability Remeasurement (Gain) Loss

Details underlying benefits, interest credited, policyholder liability remeasurement (gain) loss (in millions) and loss ratios by product line were as follows:

For the Three Months Ended March 31,
20242023
Benefits, Interest Credited and Policyholder
Liability Remeasurement (Gain) Loss by
Product Line
Life$380$386
Disability549517
Dental3535
Total benefits, interest credited and policyholder
liability remeasurement (gain) loss$964$938
Loss Ratios by Product Line
Life76.1%80.4%
Disability74.2%71.4%
Dental76.5%76.4%
Total75.0%75.0%

Generally, we experience higher mortality in the first quarter of the year and higher disability claims in the fourth quarter of the year due to the seasonality of claims. For additional information on our loss ratios, see “Additional Information” above.

For the Three Months Ended March 31,
20242023
Commissions and Other Expenses
Commissions$109$106
General and administrative expenses209212
Taxes, licenses and fees3736
Total expenses incurred355354
DAC deferrals(29)(25)
Total expenses recognized before amortization326329
DAC amortization2623
Other intangible amortization89
Total commissions and other expenses$360$361
DAC Deferrals
As a percentage of insurance premiums2.3%2.0%

Commissions and other expenses that result directly from and are essential to the successful acquisition of new or renewal business are deferred to the extent recoverable and are amortized on a constant level basis over the expected term of the related contracts using the groupings and actuarial assumptions consistent with those used for calculating the related policyholder liability balances. Certain broker commissions that vary with and are related to paid premiums are expensed as incurred rather than deferred and amortized.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.